Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard S Nicholas

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Cochrane Database of Systematic Reviews|January 23, 2009
Anticholinergics for urinary symptoms in multiple sclerosisRichard S Nicholas, Tim Friede, Sally Hollis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trialsRichard S Nicholas, Erika Han, Joel Raffel, et al.
Frontiers in Cellular Neuroscience|July 23, 2020
Aging, Cellular Senescence, and Progressive Multiple SclerosisDimitrios Papadopoulos, Roberta Magliozzi, Dimos D Mitsikostas, et al.
Immunology|October 9, 2012
Increased HLA-E expression in white matter lesions in multiple sclerosisPascal F Durrenberger, Louise V Webb, Malcolm J W Sim, et al.
Journal of Neurology|January 23, 2022
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regressionDimitrios Papadopoulos, Panagiotis Gklinos, Giorgos Psarros, et al.
BMJ Open|June 17, 2021
Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic studyRoshan das Nair, Rachael Hunter, Afagh Garjani, et al.
Neurology|May 18, 2018
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosisAntonio Scalfari, Chiara Romualdi, Richard S Nicholas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2020
Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry studyRichard S Nicholas, Martin L Heaven, Rodden M Middleton, et al.
BMC Neurology|May 4, 2015
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunityRichard S Nicholas, Vassiliki Kostadima, Maya Hanspal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 2006
A novel role for Sema3A in neuroprotection from injury mediated by activated microgliaHenry H Majed, Siddharthan Chandran, Simone P Niclou, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Cochrane Database of Systematic Reviews|January 23, 2009
Anticholinergics for urinary symptoms in multiple sclerosisRichard S Nicholas, Tim Friede, Sally Hollis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trialsRichard S Nicholas, Erika Han, Joel Raffel, et al.
Frontiers in Cellular Neuroscience|July 23, 2020
Aging, Cellular Senescence, and Progressive Multiple SclerosisDimitrios Papadopoulos, Roberta Magliozzi, Dimos D Mitsikostas, et al.
Immunology|October 9, 2012
Increased HLA-E expression in white matter lesions in multiple sclerosisPascal F Durrenberger, Louise V Webb, Malcolm J W Sim, et al.
Journal of Neurology|January 23, 2022
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regressionDimitrios Papadopoulos, Panagiotis Gklinos, Giorgos Psarros, et al.
BMJ Open|June 17, 2021
Challenges of developing, conducting, analysing and reporting a COVID-19 study as the COVID-19 pandemic unfolds: an online co-autoethnographic studyRoshan das Nair, Rachael Hunter, Afagh Garjani, et al.
Neurology|May 18, 2018
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosisAntonio Scalfari, Chiara Romualdi, Richard S Nicholas, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2020
Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry studyRichard S Nicholas, Martin L Heaven, Rodden M Middleton, et al.
BMC Neurology|May 4, 2015
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunityRichard S Nicholas, Vassiliki Kostadima, Maya Hanspal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 2006
A novel role for Sema3A in neuroprotection from injury mediated by activated microgliaHenry H Majed, Siddharthan Chandran, Simone P Niclou, et al.
Pageof 2